Study flow chart and diagnosis at discharge from ED

Slides:

Advertisements

Similar presentations

Patient Oriented Therapy Non STE ACS

Advertisements

FACEMs, Emergency Department

Tobias Reichlin, W. Hochholzer, C. Stelzig, K. Laule, M. Potocki, K

Trial profile Fox K et al. Lancet 2008;372:

Overly concerning and falsely reassuring?? FRAMINGHAM RISK FACTORS IN THE ED.

Development of Clinical Pathways to Streamline Care for Patients Presenting with Suspected Cardiac Chest Pain Background The National Heart Foundation.

Coronary Artery Disease Angina Pectoris Unstable Angina Variant Angina Joseph D. Lynch, MD.

DR. ZAHOOR 1.  A 50 year old man presents to clinic with a complaint of central chest discomfort of 2 weeks’ duration, occurring after walking for more.

ANGINA IS CHEST PAIN OR DISCOMFORT THAT HAPPENS WHEN AN AREA OF YOUR HEART MUSCLE DOESN'T GET ENOUGH OXYGEN-RICH BLOOD.

Enzymes, Cardiac Markers, Hepatic Tests clinically useful enzymes: tissue sources preanalytical variables affecting enzyme activities isoenzymes myocardial.

Coronary Heart Disease (CHD) László Tornóci Inst. Pathophysiology Semmelweis University.

Chest Pain in the Emergency Department Junior Teaching C. Brown August 2015.

Cost Containment: Use of Troponin testing in the Inpatient Wards Setting Neal Kaushal, R2 DSR2, May 2013.

Date of download: 9/17/2016 Copyright © The American College of Cardiology. All rights reserved. From: 2014 AHA/ACC Guideline for the Management of Patients.

Coronary artery disease

(CCTA, computed coronary tomography angiography; CMR, cardiac magnetic resonance; ECG, electrocardiogram; Echo, echocardiography; IHD, ischemic heart disease;

Volume 81, Issue 10, Pages (October 2010)

Risk stratification in ACS F.Shakib .cardiologigst

Ischemic Heart Disease

Cocaine-Related Chest Pain: The Year After

Tobias Reichlin, M. D. , Willibald Hochholzer, M. D

Copyright © 2009 American Medical Association. All rights reserved.

Coronary artery disease

Figure 3 Ischaemic outcomes in the ST-segment elevation myocardial

Section A: Introduction

Recent Temporal Trends in the Presentation, Management, and Outcome of Women Hospitalized with Acute Coronary Syndromes Avi Sabbag, MD, Shlomi Matetzky,

Five Things You Need to Know About Secondary Prevention Post-ACS

Cost-Effectiveness of Introducing Point-of-Care Test for Detection of Level of Glycogen Phosphorylase in Early Diagnostic Algorithm of Acute Coronary.

P2Y12 blockade versus placebo; risk ratio with 95% CIs for the primary composite end point of cardiovascular death, non-fatal myocardial infarction and.

Attributable Cost and Length of Stay for Patients with Enoxaparin-Associated Bleeding Surasak Saokaew, PharmD, Narinee Khaisombat, MSc, Nathorn Chaiyakunapruk,

Undetectable High Sensitivity Cardiac Troponin T Level in the Emergency Department and Risk of Myocardial Infarction Nadia Bandstein, MD; Rickard Ljung,

Undetectable High Sensitivity Cardiac Troponin T Level in the Emergency Department and Risk of Myocardial Infarction Nadia Bandstein, MD; Rickard Ljung,

Early and long-term outcomes of coronary artery bypass grafting in patients with acute coronary syndrome versus stable angina pectoris Toshihiro Fukui,

Flow chart of the study population according to thienopyridines used in the FAST-MI registry in patients with STEMI and NSTEMI. FAST-MI, French Registry.

High Sensitivity Troponin (hsTnT) : Result Interpretation Matrix*

Flow Diagram of the Trial Selection Process

Flow chart of the Jakarta Cardiovascular Care Unit (CCU) Network System. Flow chart of the Jakarta Cardiovascular Care Unit (CCU) Network System. There.

(A) Meta-analysis of repeat revascularisation in randomised trials.

Forest plots of randomised controlled trials and propensity score matched studies examining outcomes between patients taking proton pump inhibitor (PPIs)

Absolute ST segment elevation at the beginning of the primary percutaneous coronary intervention procedure (A), after guidewire passage (B), after thrombus.

Algorithm for the investigation of patients with elevated cardiac troponin concentrations in the context of an alternative acute illness. Algorithm for.

Flow diagram of Coronary Artery Bypass Graft-Acute Coronary Syndrome (CABG-ACS) trial. Flow diagram of Coronary Artery Bypass Graft-Acute Coronary Syndrome.

Associations between atmospheric chemistry transport model pollution concentrations at lags 0, 1 and 2 and myocardial infarction (% change in risk per.

Flow chart showing reinterventions by type in patients with anomalous origin of coronary artery from the pulmonary artery patients, divided into early.

Flow chart of the cohort selection for the study

Any, acute and subacute stent thrombosis with bivalirudin versus unfractionated heparin (UFH) in predominantly ST segment elevation myocardial infarction.

(A) The types of costs that were included in the analysis, and (B) the types of costs that were not included (modified from Torrance et al27). *Indicates.

Multivariate Cox survival analysis with predictors of mortality after adjusting for comorbidities and DBT. COPD, chronic obstructive pulmonary disease;

Major bleeding with bivalirudin versus unfractionated heparin (UFH) in predominantly ST segment elevation myocardial infarction (STEMI) studies; (A) glycoprotein.

MRRs and EMRRs for women with ACS

New electrode placement ECG from a female, age 57 with acute chest pain, shows abnormal ST elevation in leads 11, 111, aVF, V5, V6: typical findings of.

A model of variation and accelerating factors in the process of acute care chain of patients with STEMI going for primary PCI. PCI, percutaneous coronary.

(Case 1) ST segment depression attributable to myocardial ischaemia (non-infarction)—ECG demonstrated NSR with ST segment depression in the anterolateral.

Decision tree (using the CHAID algorithm) for predicting participation in a cardiac prevention and rehabilitation programme (CPRP) among 420 Jewish and.

The Need for Serial Troponin Testing absolute cTn elevations are seen in multiple chronic cardiac and noncardiac conditions rise or fall !! in serial.

Cardiac death, target vessel myocardial infarction (MI), target lesion revascularisation (TLR) by Kaplan-Meier method. Cardiac death, target vessel myocardial.

Result of coronary angiogram among patients with and without diabetes admitted with first-time acute coronary syndrome (a significant stenosis was defined.

Major bleeding with bivalirudin versus unfractionated heparin (UFH) in predominantly non-ST segment elevation acute coronary syndrome (NSTE-ACS) studies;

Prasugrel versus clopidogrel; risk ratio with 95% CIs for the primary composite end point of cardiovascular death, non-fatal myocardial infarction and.

Javier Escaned et al. JCIN 2018;11:

Use of evidence-based cardiac medications before, during and after hospitalisation for the index event in (A) overall ACS population and (B) patients with.

Distribution of left atrial (LA) remodel.

Performance of the Manchester Acute Coronary Syndromes decision rule with high-sensitivity cardiac troponin T (hs-cTnT) as the reference standard for the.

Performance of the Manchester Acute Coronary Syndromes decision rule in the validation study. Performance of the Manchester Acute Coronary Syndromes decision.

Flow diagram of study conduct.

FFR guided deferral of PCI in patients with ACS and stable coronary artery disease (SCAD). FFR guided deferral of PCI in patients with ACS and stable coronary.

Proportions of the social isolation—AMI and stroke excess risk mediated by biological, behavioural, socioeconomic and health-related factors. Proportions.

Proposed future revascularisation strategy in patients with ESRD based on our current results and previous guideline recommendations. Proposed future revascularisation.

Performance of the Manchester Acute Coronary Syndromes decision rule in the derivation study. Performance of the Manchester Acute Coronary Syndromes decision.

Cardioprotective effects of ivabradine administration in the setting of acute coronary syndromes and myocardial infarction. Cardioprotective effects of.

Presentation transcript:

Study flow chart and diagnosis at discharge from ED Study flow chart and diagnosis at discharge from ED. ACS, acute coronary syndrome; CCP, cardiac chest pain; ED, emergency department; EMT, emergency medical transport; GI: gastrointestinal disorders; GP, general practitioner, NCCP, non-CCP; NCCP-K, NCCP of ... Study flow chart and diagnosis at discharge from ED. ACS, acute coronary syndrome; CCP, cardiac chest pain; ED, emergency department; EMT, emergency medical transport; GI: gastrointestinal disorders; GP, general practitioner, NCCP, non-CCP; NCCP-K, NCCP of known origin; NCCP-U, NCCP of unknown origin; NSTEMI, non-STEMI; STEMI, ST-elevated myocardial infarction; UAP, unstable angina pectoris. Karen Anne Mol et al. Open Heart 2018;5:e000859 ©2018 by British Cardiovascular Society